Brief: Tracon Pharmaceuticals Announces FDA Approval Of Amended Envasarc Protocol
10/03/2022 14:24
March 10 (Reuters) - TRACON Pharmaceuticals Inc TCON.O :
* TRACON PHARMACEUTICALS ANNOUNCES FDA APPROVAL OF AMENDED
ENVASARC PROTOCOL
* TRACON PHARMACEUTICALS ANNOUNCES FDA APPROVAL OF AMENDED
ENVASARC PROTOCOL
Source text for Eikon: ID:nGNXLYJYZ
Further company coverage: TCON.O
((reuters.briefs@thomsonreuters.com;))
Recent news on TRACON Pharmaceuticals
See all newsBrief: TRACON Pharmaceuticals Says ENVASARC Trial ORR Is 5%, Does Not Meet 11% Endpoint
Tracon Pharmaceuticals Inc Reports Results For The Quarter Ended In March: Earnings Summary
Tracon Pharmaceuticals Inc Expected To Post A Loss Of $1.19 A Share: Earnings Preview
Tracon Pharmaceuticals Inc Expected To Post A Loss Of $1.19 A Share: Earnings Preview
Brief: Tracon Pharmaceuticals Files For Offering Of Common Stock, Pre-Funded Warrants